When was Deltanoid founded?

Deltanoid was founded in 2000 and raised its 1st funding round 7 years after it was founded.

Where is Deltanoid located?

Deltanoid is headquartered in Madison, United States.

How many employees does Deltanoid have?

As of Apr 30, 2026, the latest employee count at Deltanoid is 3.

Is Deltanoid a funded company?

Deltanoid is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Dec 17, 2007.

When was the latest funding round of Deltanoid?

Deltanoid's latest funding was a $***** Series B round on Dec 17, 2007, with participation from 3 investors. Its primary sector is Diversified Pharmaceuticals. In United States, the Diversified Pharmaceuticals sector has seen $85.4M in funding in 2026 to date.

Deltanoid - 2026 Company Profile, Team & Funding

Deltanoid is a deadpooled company based in Madison (United States), founded in 2000. It operates as a Vitamin D Analogs for the treatment of secondary hyperparathyroidism and acne.. Deltanoid has raised $12M in funding.

Company Details

Deltanoid Pharmaceuticals, a clinical stage company focused on unlocking the power of the vitamin D receptor (VDR) to transform health outcomes for patients with diseases of the kidney, bone, and skin. It is developing therapies derived from vitamin D-based compounds originally discovered at the University of Wisconsin-Madison. Its flagship compound DP001 is currently under development for the treatment of secondary hyperparathyroidism. Also developing DP006 that acts in skin w being developed which is for the treatment of acne.

Website: deltanoid.com
Email ID: *****@deltanoid.com

Key Metrics

Founded Year

2000

Location

Madison, United States

Stage

Deadpooled

Total Funding

$12M in 1 round

Latest Funding Round

Series B, Dec 17, 2007, $*****

Investors

WARF & 2 more

Employee Count

3 as on Apr 30, 2026

View Deltanoid's full profile

Deltanoid has raised a total funding of $12M over 1 round. Its latest funding round was a Series B round on Dec 17, 2007 for $*****. 3 investors participated in its latest round. Deltanoid has 3 institutional investors.